Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016983 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- From Formulation Search to Scientific Q&A: Automat Launches Integrated Electrolyte Intelligence Workspace
- CareRx Announces Q3 2026 Dividend
- Emerging Growth Research Reiterates Buy-Emerging Rating on Faraday Future Intelligent Electric and Updates 12-Month Price Target to $30 Following Reverse Stock Split
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
